Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial "CABANA"
Recruiting
Phase N/A Results N/ASummary of Purpose
The (Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial) CABANA Trial has the overall goal of establishing the appropriate roles for medical and ablative intervention for atrial fibrillation (AF). The CABANA Trial is designed to test the hypothesis that the treatment strategy of left atrial catheter ablation for the purpose of eliminating atrial fibrillation (AF) will be superior...
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 5 March 2013.
| 1 Aug 2009 | 28 May 2009 | 1 Mar 2015 | 1 Sep 2015 | 1 Mar 2013 | Unavailable |
| Start Date | First Received | 1st Completion | Completion | Verification | Results |
|---|
Trial Design
- Allocation: Randomized
- Masking: Open Label
- Purpose: Treatment
- Endpoint: Efficacy Study
- Intervention: Parallel Assignment
Contacts
- Kristi H. Monahan, RN, BSM
CABANA@mayo.edu 507-255-6676
- Shari Rolbiecki
CABANA@mayo.edu 507-538-4358
- Kristi H. Monahan, RN, AS
CABANA@mayo.edu 507-255-6676
View Trial Locations
Recruitment
- Enrollment: 3,000
- Gender: Both
- Minimum Age: 18 Years
- Accepts Healthy Volunteers: No
- 205 locations, 13 countries
Principal Investigators
- Douglas L. Packer, M.D.
Mayo Clinic
- Kerry L. Lee, Ph.D.
Duke University
- Daniel B. Mark, M.D., MPH
Duke University
